Clinical Trial Update: Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial completed evaluating the reliability of a top mount actuation indicator for a levalbuterol metered-dose inhaler in adults and pediatric subjects…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Levalbuterol (Levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED